RGD-30092-29733
3 vaccinations
2 coded responses
11 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 430 / OH
- Registered
- 2021-01-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
DJL-31728-36821
Child or adolescent in my care · Female · 2021-11-08
Timeline
-
2021-01-17
Registered in v-safe
-
2021-01-17
Dose 1 — Pfizer-BioNTech
-
2021-01-17
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-17
Report sent to call center — day 0, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-18
- 2021-01-19
- 2021-01-23
- 2021-01-31
-
2021-02-07
Dose 2 — Pfizer-BioNTech
-
2021-02-07
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-14
Survey response — day 7, dose 2MedDRA: Rhinorrhoea — Feeling: Fair · HeadacheFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-11-05
Dose 3 — Pfizer-BioNTech
-
2021-12-11
Survey response — day 35, dose 3MedDRA: Malaise, Oropharyngeal pain, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Congestion sore throat malaiseMedDRA releases: 2024-11 · check-in free text available
-
2021-12-11
Report sent to call center — day 35, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-12-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-17 | Pfizer-BioNTech | |
| 2 | 2021-02-07 | Pfizer-BioNTech | |
| 3 | 2021-11-05 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 4 — day 7, dose 2
Systemic reaction (other): Runny nose
Release 10 — day 35, dose 3
Symptoms: Congestion sore throat malaise
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Malaise | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release